Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJF4M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,521
Award facts
- Contract value 100% obligated
- $23,520.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, with a ceiling value of $23,520.58. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract calls for performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 30, 2025. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for Xeljanz XR, a specialized immunosuppressant medication, exemplifies AmerisourceBergen's role in supplying brand-name pharmaceuticals to support federal healthcare programs, leveraging its position as a prime vendor under DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26FJF4M?
SPE2DR26FJF4M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FJF4M worth?
The government has obligated $23,521 on SPE2DR26FJF4M.
Is contract SPE2DR26FJF4M an order under another contract?
Yes. SPE2DR26FJF4M is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJF4M competed?
The extent of competition for SPE2DR26FJF4M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award